Evidence of in Rodents from Bangladesh.

Vector Borne Zoonotic Dis

Wageningen University and Research, Livestock Research, Wageningen, the Netherlands.

Published: December 2019

Rodents contribute to the life cycle of the protozoan parasite as an intermediate host and key prey animal of cats, the definitive host. As there is limited scientific knowledge available about the incidence and prevalence of in commensal rodents in many Asian countries, we tested rodents from a commercial rice mill and eight local villages in Bangladesh for the presence of DNA using rodent brain material preserved in ethanol. Overall, 10 of 296 (3.4%) rodent samples tested positive for DNA. Our results indicate that rodents present in food production and food storage facilities may carry .

Download full-text PDF

Source
http://dx.doi.org/10.1089/vbz.2019.2440DOI Listing

Publication Analysis

Top Keywords

evidence rodents
4
rodents bangladesh
4
rodents
4
bangladesh rodents
4
rodents contribute
4
contribute life
4
life cycle
4
cycle protozoan
4
protozoan parasite
4
parasite intermediate
4

Similar Publications

Sulphated polysaccharides (SPs) are negatively charged compounds found in the cell wall of seaweeds or marine macro algae. These compounds exhibit a range of pharmacological activities, including anti-obesity effects. The aim of this systematic review as well as meta-analysis was to assess the potentials of seaweed-derived SPs to mitigate obesity through a systematic review and meta-analysis of animal model-based studies.

View Article and Find Full Text PDF

Spotlight on the Mechanism of Action of Semaglutide.

Curr Issues Mol Biol

December 2024

1st Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece.

Initially intended to control blood glucose levels in patients with type 2 diabetes, semaglutide, a potent glucagon-like peptide 1 analogue, has been established as an effective weight loss treatment by controlling appetite. Integrating the latest clinical trials, semaglutide in patients with or without diabetes presents significant therapeutic efficacy in ameliorating cardiometabolic risk factors and physical functioning, independent of body weight reduction. Semaglutide may modulate adipose tissue browning, which enhances human metabolism and exhibits possible benefits in skeletal muscle degeneration, accelerated by obesity and ageing.

View Article and Find Full Text PDF

Complex metabolic diseases due to overnutrition such as obesity, type 2 diabetes, and fatty liver disease are a major burden on the healthcare system worldwide. Current research primarily focuses on disease endpoints and trying to understand underlying mechanisms at relatively late stages of the diseases, when irreversible damage is already done. However, complex interactions between physiological systems during disease development create a problem regarding how to build cause-and-effect relationships.

View Article and Find Full Text PDF

Background: To explore the mechanism of hyperbaric oxygen (HBO) intervention on acute lung injury secondary to snake venom poisoning and provide more toxicological and clinical evidence for venom poisoning.

Methods: Male Kunming mice (n = 96) were randomly divided into four groups: the control group which was not given any interventional treatments, venom group in which each mouse was injected with venom (1 mg/kg) through the tail vein, antivenom group in which each mouse was injected with anti- venom immediately after the model was successfully established, and HBO+antivenom group in which each mouse was given HBO treatment at 1 h, 5 h, 11 h and 23 h following the injection of antivenom. Lung tissues of mice were obtained and processed for the detection of the lung coefficient, the levels of inflammatory factors such as interleukin (IL)-6, IL-10 and IL-17, and the protein expression of retinoic acid receptor (RAR)-related orphan receptor gamma (RORγt) and forkhead box P3 (FOXP3).

View Article and Find Full Text PDF

The development of ground-breaking Survival Motor Neuron (SMN) replacement strategies has revolutionized the field of Spinal Muscular Atrophy (SMA) research. However, the limitations of these therapies have now become evident, highlighting the need for the development of complementary targets beyond SMN replacement. To address these challenges, here we explored, in in vitro and in vivo disease models, Stathmin-2 (STMN2), a neuronal microtubule regulator implicated in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), as a novel SMN-independent target for SMA therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!